← Back to Patent Explorer
US5236956A Expired / Lapsed US ⏱️ 0.0 years remaining

Compounds for the treatment of urinary incontinence

Assignee: Pfizer Health AB
•
Filing: 1991-10-07
•
Granted: 1993-08-17
•
Expires: 2011-10-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention concerns compounds having the formula I ##STR1## wherein Ar is a phenyl or benzyl group which is optionally substituted with hydroxy or alkoxy; R 1 is hydrogen, lower alkyl, lower alkoxy, hydroxy; R 2 is hydrogen, lower alkyl; R 3 is NR 4 R 5 , wherein R 4 and R 5 which can be the same or different, are lower alkyl, or wherein R 4 and R 5 , when taken together, form a ring with the nitrogen atom, whereby said ring optionally is substituted with lower alkyl; n is 0 or 1; m is 2 or 3 and their salts with physiologically acceptable acids and when the compounds can be in form of optical isomers, the racemic mixture and the individual isomers, for the treatment of disorders of the urinary bladder.

Inventors

  • 👤 Christer Sjogren
  • 👤 Rene Mollberg
  • 👤 Sten Kelfve

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 23:34
CPC Classifications
C; C07; C07D; C07D295/00; C07D295/04; C07D295/12; C07D295/125; C07D295/13; A; A61; A61K; A61K31/00; A61K31/16; A61K31/165; A61K31/33; A61K31/395; A61K31/435; A61K31/44; A61K31/445; C07C; C07C233/00; C07C233/01; C07C233/34; C07C233/35; C07C233/40; C07C235/00; C07C235/02; C07C235/32; C07C235/34

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 102 words
Compounds having the general formula II: ##STR4## wherein Ar is a phenyl group which is optionally substituted with hydroxy; R 1 is hydrogen or lower alkyl; R 2 is hydrogen or lower alkyl; R 7 and R 8 which can be the same or different, are lower alkyl, wherein one or both of R 7 and R 8 is branched and the total number of carbon atoms in R 7 and R 8 is at least 6; their salts with physiologically acceptable acids and, when the compounds can be in the form of optical isomers, the racemic mixture and the individual enantiomers.
Claim 2
Dependent Claim 102 words
Compounds having the general formula II: ##STR4## wherein Ar is a phenyl group which is optionally substituted with hydroxy; R 1 is hydrogen or lower alkyl; R 2 is hydrogen or lower alkyl; R 7 and R 8 which can be the same or different, are lower alkyl, wherein one or both of R 7 and R 8 is branched and the total number of carbon atoms in R 7 and R 8 is at least 6; their salts with physiologically acceptable acids and, when the compounds can be in the form of optical isomers, the racemic mixture and the individual enantiomers.
Claim 3
Dependent Claim 15 words
Compounds according to claim 1 characterized in that R 7 and R 8 are isopropyl.
Claim 4
Dependent Claim 14 words
The compounds of claim 1, selected from the group consisting of: N-methyl-N-(2-diisopropylaminoethyl)-2,2-diphenylacetamide N-(2-diisopropylaminoethyl)-2,2-diphenylacetamide N-methyl-N-(2-diisopropylaminoethyl)-2-methyl-2,2-diphenylacetamide.
Claim 5
Dependent Claim 15 words
A pharmaceutical composition comprising a compound according to claim 1 with a pharmaceutically acceptable carrier.
Claim 6
Dependent Claim 15 words
A pharmaceutical composition comprising a compound according to claim 2 with a pharmaceutically acceptable carrier.
Claim 7
Dependent Claim 15 words
A pharmaceutical composition comprising a compound according to claim 3 with a pharmaceutically acceptable carrier.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1996-08-16 1997-02-15 1997-08-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2000-08-16 2001-02-15 2001-08-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2004-08-16 2005-02-15 2005-08-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag